Trademark: 79298532
Word
UPCARE
Status
Registered
Status Code
700
Status Date
Tuesday, February 22, 2022
Serial Number
79298532
Registration Number
6648773
Registration Date
Tuesday, February 22, 2022
Mark Type
3000
Filing Date
Wednesday, October 21, 2020
Published for Opposition
Tuesday, December 7, 2021

Trademark Owner History
APEX BIOTECH RESEARCH PTY LTD - Original Registrant

Classifications
5 Acne treatment preparations in the form of cleansers; anti-bacterial pharmaceutical preparations; Capsules sold empty for pharmaceutical purposes; effervescent analgesic pharmaceutical preparations; Extracts of plants in capsule form for pharmaceutical purposes; Throat lozenges for pharmaceutical purposes; pharmaceutical compound eye-drops; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations containing vitamins for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations for animals for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations for health care for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations for human use for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations for nasal use for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations for oral use for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations for personal use for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of acne; Pharmaceutical preparations for veterinary use for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations in the form of emulsions for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations in the form of throat lozenges; Pharmaceutical preparations in the form of tablets for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical products for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical products derived from natural sources for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical products for use by humans for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical products in gel form for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical tablets for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; plant extracts for pharmaceutical use; Drug delivery agents in the form of tablets that facilitate the delivery of pharmaceutical preparations; medicated mouth spray; mouth sprays for medical use; medicated throat sprays; medicated mouthwashes; medical mouthwashes; mouthwashes and gargles for medical purposes; dietary supplements; dietary supplements for animals; herbal dietary supplements; vitamin supplements; vitamin supplements for animals; Nutritionally fortified herbal beverages for medicinal use; medical toothpastes; medicated toothpaste; eye drops; dietary supplements with a cosmetic effect
The mark consists of the wording "UPCARE" in black stylized font placed below two interlocking diagonal oblong shapes, with the top left shape being in red, the top right shape in green, the bottom left shape in orange and the bottom right shape in blue. The color white represents background, outlining, shading and/or transparent areas and is/are not part of the mark.
UP CARE
The color(s) black, red, blue, green and orange is/are claimed as a feature of the mark.

Trademark Events
Aug 16, 2022
Final Decision Transaction Processed By Ib
Jul 27, 2022
Final Disposition Notice Sent To Ib
Jul 27, 2022
Final Disposition Processed
May 22, 2022
Final Disposition Notice Created, To Be Sent To Ib
Feb 22, 2022
Registered-Principal Register
Dec 7, 2021
Official Gazette Publication Confirmation E-Mailed
Dec 7, 2021
Published For Opposition
Dec 6, 2021
Notification Processed By Ib
Nov 17, 2021
Notification Of Possible Opposition Sent To Ib
Nov 17, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Nov 17, 2021
Notification Of Notice Of Publication E-Mailed
Nov 1, 2021
Approved For Pub - Principal Register
Oct 5, 2021
Teas/Email Correspondence Entered
Oct 5, 2021
Correspondence Received In Law Office
Oct 5, 2021
Teas Response To Office Action Received
Apr 25, 2021
Refusal Processed By Ib
Apr 5, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Apr 5, 2021
Refusal Processed By Mpu
Mar 29, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Mar 28, 2021
Non-Final Action Written
Mar 22, 2021
Assigned To Examiner
Dec 8, 2020
Application Filing Receipt Mailed
Dec 2, 2020
New Application Office Supplied Data Entered In Tram
Nov 26, 2020
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24